Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli isolated from patients with community-onset infections in Chinese county hospitals

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Zhang, Jing ^a   Zheng, Beiwen ^a   Zhao, Lina ^a   Wei, Zeqing ^a   Ji, Jinru ^a   Li, Lanjuan ^a   Xiao, Yonghong ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; BETA LACTAMASE CTX M; BIAPENEM; CEFAZOLIN; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; FOSFOMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; AMPC BETA-LACTAMASES; BACTERIAL DNA; BACTERIAL PROTEIN; BETA LACTAMASE; BETA-LACTAMASE CTX-M, E COLI; BETA-LACTAMASE CTX-M-55, E COLI; ESCHERICHIA COLI PROTEIN; GENETIC MARKER;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; BLA CTX M 14 GENE; BLA CTX M 15 GENE; BLA CTX M 55 GENE; BLA CTX M GENE; CHINA; CHINESE; COMMUNITY ACQUIRED INFECTION; CONTROLLED STUDY; DISK DIFFUSION; DNA SEQUENCE; ENZYME ACTIVITY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; UPREGULATION; YOUNG ADULT; ADOLESCENT; AGED; BACTERIUM IDENTIFICATION; CLASSIFICATION; COMMUNITY-ACQUIRED INFECTIONS; ENZYMOLOGY; ESCHERICHIA COLI INFECTIONS; GENETIC MARKER; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PUBLIC HOSPITAL; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CHINA; COMMUNITY-ACQUIRED INFECTIONS; DNA, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; GENETIC MARKERS; GENOTYPE; HOSPITALS, COUNTY; HUMANS; MALE; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; POLYMERASE CHAIN REACTION; PREVALENCE; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84923914694     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-014-0659-0     Document Type: Article

References (58)

1. Bradford PA: Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001, 14(4):933-951. table of contents.
2. Bush K, Jacoby GA, Medeiros AA: A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995, 39(6):1211.
3. Mutter GL, Baak JP, Fitzgerald JT, Gray R, Neuberg D, Kust GA, Gentleman R, Gullans SR, Wei LJ, Wilcox M: Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol Oncol 2001, 83(2):177-185.
4. Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, Ayala J, Coque TM, Kern-Zdanowicz I, Luzzaro F, Poire L, Woodford N: CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2007, 59(2):165-174.
5. Doi Y, Park YS, Rivera JI, Adams-Haduch JM, Hingwe A, Sordillo EM, Lewis JS 2nd, Howard WJ, Johnson LE, Polsky B, Jorgensen JH, Richter SS, Shutt KA, Paterson DL: Community-associated extended-spectrum beta-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis 2013, 56(5):641-648.
6. Rogers BA, Sidjabat HE, Paterson DL: Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 2011, 66(1):1-14.
7. Yu Y, Ji S, Chen Y, Zhou W, Wei Z, Li L, Ma Y: Resistance of strains producing extended-spectrum beta-lactamases and genotype distribution in China. J Infect 2007, 54(1):53-57.
8. da Silva Dias RC, Borges-Neto AA, D'Almeida Ferraiuoli GI, de-Oliveira MP, Riley LW, Moreira BM: Prevalence of AmpC and other beta-lactamases in enterobacteria at a large urban university hospital in Brazil. Diagn Microbiol Infect Dis 2008, 60(1):79-87.
9. Munday C, Xiong J, Li C, Shen D, Hawkey P: Dissemination of CTX-M type β-lactamases in Enterobacteriaceae isolates in the People's Republic of China. Int J Antimicrob Agents 2004, 23(2):175-180.
10. Baurin S, Vercheval L, Bouillenne F, Falzone C, Brans A, Jacquamet L, Ferrer JL, Sauvage E, Dehareng D, Frere JM, Charlier P, Galleni M, Kerff F: Critical role of tryptophan 154 for the activity and stability of class D beta-lactamases. Biochemistry 2009, 48(47):11252-11263.
11. Baas PW, Ahmad FJ: Force generation by cytoskeletal motor proteins as a regulator of axonal elongation and retraction. Trends Cell Biol 2001, 11(6):244-249.
12. Lartigue MF, Zinsius C, Wenger A, Bille J, Poirel L, Nordmann P: Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland. Antimicrob Agents Chemother 2007, 51(8):2855-2860.
13. Arpin C, Quentin C, Grobost F, Cambau E, Robert J, Dubois V, Coulange L, Andre C: Scientific committee of O: nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting. J Antimicrob Chemother 2009, 63(6):1205-1214.
14. Khanna N, Boyes J, Lansdell PM, Hamouda A, Amyes SG: Molecular epidemiology and antimicrobial resistance pattern of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in Glasgow, Scotland. J Antimicrob Chemother 2012, 67(3):573-577.
15. Livermore DM, Hawkey PM: CTX-M: changing the face of ESBLs in the UK. J Antimicrob Chemother 2005, 56(3):451-454.
16. Rawat V, Singhai M, Verma PK: Detection of different beta-Lactamases and their co-existence by using various discs combination methods in clinical isolates of enterobacteriaceae and pseudomonas spp. J Lab Phys 2013, 5(1):21-25.
17. Bell JM, Turnidge JD, Gales AC, Pfaller MA, Jones RN, Sentry ASG: Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). Diagn Microbiol Infect Dis 2002, 42(3):193-198.
18. Heffernan HM, Woodhouse RE, Pope CE, Blackmore TK: Prevalence and types of extended-spectrum beta-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand. Int J Antimicrob Agents 2009, 34(6):544-549.
19. Liu W, Chen L, Li H, Duan H, Zhang Y, Liang X, Li X, Zou M, Xu L, Hawkey PM: Novel CTX-M {beta}-lactamase genotype distribution and spread into multiple species of Enterobacteriaceae in Changsha, Southern China. J Antimicrob Chemother 2009, 63(5):895-900.
20. Yang Q, Zhang H, Wang Y, Xu Y, Chen M, Badal RE, Wang H, Ni Y, Yu Y, Hu B, Sun Z, Huang W, Wang Y, Wu A, Feng X, Liao K, Shen D, Hu Z, Chu Y, Lu J, Cao B, Su J, Gui B, Duan Q, Zhang S, Shao H, Kong H, Hu Y, Ye H: A 10 year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community- and hospital-associated intra-abdominal infections in China. J Med Microbiol 2013, 62(Pt 9):1343-1349.
21. Xiao YH, Giske CG, Wei ZQ, Shen P, Heddini A, Li LJ: Epidemiology and characteristics of antimicrobial resistance in China. Drug Resist Updat 2011, 14(4-5):236-250.
22. Xiao Y, Zhang J, Zheng B, Zhao L, Li S, Li L: Changes in Chinese policies to promote the rational use of antibiotics. PLoS Med 2013, 10(11):e1001556.
23. Xiao Y, Shen P, Wei Z, Chen Y, Kong H, Yang Q, Zhang W, Chen X, Li L: National surveillance of antimicrobial resistance of Mohnarin. Chin J Nosocomiology 2012, 22(22):4946-4952.
24. Jiang S, Zheng B, Ding W, Lv L, Ji J, Zhang H, Xiao Y, Li L: Whole-genome sequence of Staphylococcus hominis, an opportunistic pathogen. J Bacteriol 2012, 194(17):4761-4762.
25. Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing. 21th Informational Supplement, Document M100-S21s. Wayne, PA, USA: CLSI; 2011.
26. Holmes DS, Quigley M: A rapid boiling method for the preparation of bacterial plasmids. Anal Biochem 1981, 114(1):193-197.
27. Dallenne C, Da Costa A, Decre D, Favier C, Arlet G: Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J Antimicrob Chemother 2010, 65(3):490-495.
28. Zhang W, Luo Y, Li J, Lin L, Ma Y, Hu C, Jin S, Ran L, Cui S: Wide dissemination of multidrug-resistant Shigella isolates in China. J Antimicrob Chemother 2011, 66(11):2527-2535.
29. Sun Y, Zeng Z, Chen S, Ma J, He L, Liu Y, Deng Y, Lei T, Zhao J, Liu JH: High prevalence of bla(CTX-M) extended-spectrum beta-lactamase genes in Escherichia coli isolates from pets and emergence of CTX-M-64 in China. Clin Microbiol Infect 2010, 16(9):1475-1481.
30. Zhang KJ, Han X, Hong XY: Various infection status and molecular evidence for horizontal transmission and recombination of Wolbachia and Cardinium among rice planthoppers and related species. Insect Sci 2013, 20(3):329-344.
31. Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, Karch H, Reeves PR, Maiden MC, Ochman H, Achtman M: Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 2006, 60(5):1136-1151.
32. Hu YY, Cai JC, Zhou HW, Chi D, Zhang XF, Chen WL, Zhang R, Chen GX: Molecular typing of CTX-M-producing escherichia coli isolates from environmental water, swine feces, specimens from healthy humans, and human patients. Appl Environ Microbiol 2013, 79(19):5988-5996.
33. Zhuo C, Su D, Li H, Wang L, Liao K, Wang M, Zhi Z, Guo Z, Wei Y, Geng H: Study on CIX-M type ESBLs-producing Escherichia coli and Klebsiella pneumoiae in Guangzhou. Chin J Lab Med 2009, 32(10):1114-1119.
34. Kiratisin P, Apisarnthanarak A, Saifon P, Laesripa C, Kitphati R, Mundy LM: The emergence of a novel ceftazidime-resistant CTX-M extended-spectrum beta-lactamase, CTX-M-55, in both community-onset and hospital-acquired infections in Thailand. Diagn Microbiol Infect Dis 2007, 58(3):349-355.
35. Shi W-F, Zhou J, Qin J-P: Transconjugation and genotyping of the plasmid-mediated AmpC beta-lactamase and extended-spectrum beta-lactamase genes in Klebsiella pneumoniae. Chin Med J (Engl) 2009, 122(9):1092-1096.
36. Sjolund-Karlsson M, Howie R, Krueger A, Rickert R, Pecic G, Lupoli K, Folster JP, Whichard JM: CTX-M-producing non-Typhi Salmonella spp. isolated from humans, United States. Emerg Infect Dis 2011, 17(1):97-99.
37. Dahmen S, Madec JY, Haenni M: F2:A-:B- plasmid carrying the extended-spectrum beta-lactamase bla(CTX-M-55/57) gene in Proteus mirabilis isolated from a primate. Int J Antimicrob Agents 2013, 41(6):594-595.
38. Dinubile MJ, Friedland I, Chan CY, Motyl MR, Giezek H, Shivaprakash M, Weinstein RA, Quinn JP: Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy. Eur J Clin Microbiol Infect Dis 2005, 24(7):443-449.
39. Zheng H, Zeng Z, Chen S, Liu Y, Yao Q, Deng Y, Chen X, Lv L, Zhuo C, Chen Z, Liu J: Prevalence and characterisation of CTX-M beta-lactamases amongst Escherichia coli isolates from healthy food animals in China. Int J Antimicrob Agents 2012, 39(4):305-310.
40. Ma J, Liu JH, Lv L, Zong Z, Sun Y, Zheng H, Chen Z, Zeng ZL: Characterization of extended-spectrum beta-lactamase genes found among Escherichia coli isolates from duck and environmental samples obtained on a duck farm. Appl Environ Microbiol 2012, 78(10):3668-3673.
41. Zurfluh K, Hachler H, Nuesch-Inderbinen M, Stephan R: Characteristics of extended-spectrum beta-lactamase- and carbapenemase-producing Enterobacteriaceae Isolates from rivers and lakes in Switzerland. Appl Environ Microbiol 2013, 79(9):3021-3026.
42. Li J, Ma Y, Hu C, Jin S, Zhang Q, Ding H, Ran L, Cui S: Dissemination of cefotaxime-M-producing Escherichia coli isolates in poultry farms, but not swine farms, in China. Foodborne Pathog Dis 2010, 7(11):1387-1392.
43. Seiffert SN, Hilty M, Perreten V, Endimiani A: Extended-spectrum cephalosporin-resistant gram-negative organisms in livestock: an emerging problem for human health? Drug Resist Updat 2013, 16(1-2):22-45.
44. Winokur P, Vonstein D, Hoffman L, Uhlenhopp E, Doern G: Evidence for Transfer of CMY-2 AmpC β-Lactamase Plasmids between Escherichia coli andSalmonella Isolates from Food Animals and Humans. Antimicrob Agents Chemother 2001, 45(10):2716-2722.
45. Fey PD, Safranek TJ, Rupp ME, Dunne EF, Ribot E, Iwen PC, Bradford PA, Angulo FJ, Hinrichs SH: Ceftriaxone-resistant Salmonella infection acquired by a child from cattle. N Engl J Med 2000, 342(17):1242-1249.
46. Angulo FJ, Mølbak K: Human health consequences of antimicrobial drug-resistant salmonella and other foodborne pathogens. Clin Infect Dis 2005, 41(11):1613-1620.
47. Li XZ, Mehrotra M, Ghimire S, Adewoye L: beta-Lactam resistance and beta-lactamases in bacteria of animal origin. Vet Microbiol 2007, 121(3-4):197-214.
48. Cao X, Cavaco LM, Lv Y, Li Y, Zheng B, Wang P, Hasman H, Liu Y, Aarestrup FM: Molecular characterization and antimicrobial susceptibility testing of Escherichia coli isolates from patients with urinary tract infections in 20 Chinese hospitals. J Clin Microbiol 2011, 49(7):2496-2501.
49. Pitout JD, Gregson DB, Campbell L, Laupland KB: Molecular characteristics of extended-spectrum-β-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob Agents Chemother 2009, 53(7):2846-2851.
50. Lau SH, Kaufmann ME, Livermore DM, Woodford N, Willshaw GA, Cheasty T, Stamper K, Reddy S, Cheesbrough J, Bolton FJ: UK epidemic Escherichia coli strains A-E, with CTX-M-15 β-lactamase, all belong to the international O25: H4-ST131 clone. J Antimicrob Chemother 2008, 62(6):1241-1244.
51. Smet A, Martel A, Persoons D, Dewulf J, Heyndrickx M, Claeys G, Lontie M, Van Meensel B, Herman L, Haesebrouck F: Characterization of extended-spectrum β-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections. Microb Drug Resist 2010, 16(2):129-134.
52. Wu Y, Li H, Li J, Huang ZH: Detection of Pseudomonas aeruginosa carried a new array of gene cassettes within class 1 integron isolated from a teaching hospital in Nanjing, China. J Microbiol 2008, 46(6):687-691.
53. Girlich D, Poirel L, Leelaporn A, Karim A, Tribuddharat C, Fennewald M, Nordmann P: Molecular epidemiology of the integron-located VEB-1 extended-spectrum beta-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand. J Clin Microbiol 2001, 39(1):175-182.
54. Kiratisin P, Apisarnthanarak A, Laesripa C, Saifon P: Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agents Chemother 2008, 52(8):2818-2824.
55. Poirel L, Schrenzel J, Cherkaoui A, Bernabeu S, Renzi G, Nordmann P: Molecular analysis of NDM-1-producing enterobacterial isolates from Geneva, Switzerland. J Antimicrob Chemother 2011, 66(8):1730-1733.
56. Huovinen P, Huovinen S, Jacoby G: Sequence of PSE-2 beta-lactamase. Antimicrob Agents Chemother 1988, 32(1):134-136.
57. Couture F, Lachapelle J, Levesque RC: Phylogeny of LCR-1 and OXA-5 with class A and class D beta-lactamases. Mol Microbiol 1992, 6(12):1693-1705.
58. Poirel L, Naas T, Nordmann P: Class D ss-lactamases: diversity, epidemiology and genetics. Antimicrob Agents Chemother 2010, 54(1):24-38.